Through its selective GH release and influence on energy balance, ipamorelin offers unique advantages in treating metabolic and hypogonadal conditions. It increases serum GH and IGF-1 levels without surpassing physiological norms, avoiding risks like edema and joint stiffness often associated with GH therapy. Ipamorelin’s unique profile has led to interest in its potential for body composition adjustments in hypogonadal men, helping reduce fat accumulation while promoting lean mass—benefits typically associated with GH, but with lower associated risks.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about IPAMORELIN 5 by Euro-Pharmacies, consult with your doctor or healthcare professional.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.
Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W. and Lipshultz, L.I., 2020. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology.
Home
